Tag: iShares Biotechnology ETF

Bristol Myers Squibb turns to China to develop new drugs in newest cross-continent collaboration

Hantavirus cases spark surge in pharma and biotech stocks — here’s why

Pharma bets a little-known form of cholesterol will underpin its next blockbuster heart drugs

Eli Lilly agrees to acquire cancer drug maker Kelonia in deal worth up to $7 billion

Trump policies, China’s biotech boom are ending Europe’s pharma powerhouse era

Stocks making the biggest moves midday: Palantir, Flutter, United Airlines, Synopsys, Insmed & more

Pfizer to seek FDA approval for Lyme disease vaccine candidate despite trial miss

Vertex passes key test in quest to treat kidney diseases

FDA vaccine head will step down in April after string of controversial decisions

FDA reversals leave investors worrying about the fates of other experimental drugs